Biomodex is formerly owned by LBO France, through LBO France Venture, since 2016.

When did LBO France acquire Biomodex?

LBO France acquired Biomodex in 2016 and exited after 7 years.

Has Biomodex been sold?

Yes. Biomodex was exited in 2023 via Trade Sale.

Healthcare·

France·Exited 2023·Held 7yr

Biomodex is a healthcare company, headquartered in France.

Entry

2016

Hold

7yr

Exit

2023

Est. EV

–

Investor

HQFrance

SectorHealthcare

Biomodex · portfolio company of LBO France. | [maintenance 2026-04-14] Dissolved operations; Mentice AB (publ, OM:MNTC) acquired all…Read full notes

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in LBO France Venture

6 comparable healthcare deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Already a member?

Data refreshed weekly · Sourced from public filings